基本信息
浏览量:0
职业迁徙
个人简介
Dr. Rajendran has a broad background in pharmacology with a proven track record in cancer chemoprevention, preclinical research, drug discovery & development. His long-term goal is to better understand the epigenetic mechanisms involved in cancer in order to help design effective strategies for both prevention and treatment of this dreadful disease. His current focus is in the broad area of gastro-intestinal (GI) cancer, and chemoprevention by organo-sulfur compounds.
研究兴趣
论文共 75 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CELL DEATH & DISEASEno. 8 (2024)
Jorge Enrique Tovar Perez, Shilan Zhang, William Hodgeman,Sabeeta Kapoor,Praveen Rajendran,Koichi S. Kobayashi,Roderick H. Dashwood
Clinical Epigeneticsno. 1 (2024): 1-17
Cancer Researchno. 6_Supplement (2024): 5276-5276
Cancersno. 6 (2024): 1104-1104
Praveen Rajendran,Gavin Johnson, Li, Ying-Shiuan Chen, Mohaiza Dashwood, Nhung Nguyen, Ahmet Ulusan, Furkan Ertem, Mutian Zhang, Jia Li, Deqiang Sun, Yun Huang, Shan Wang, Hon-Chiu Leung, David Lieberman, Laura Beaver, Emily Ho, Mark Bedford, Kyle Chang, Eduardo Vilar, Roderick Dashwood
crossref(2023)
Ahmet Uluşan,Praveen Rajendran,Wan‐Mohaiza Dashwood, Ömer Yavuz, Sudhir Kapoor,Trace A. Gustafson,Michelle I. Savage,Powel H. Brown,Shizuko Sei,Altaf Mohammed,Eduardo Vilar
openalex(2023)
Praveen Rajendran,Gavin Johnson, Li, Ying‐Shiuan Chen, Mohaiza Dashwood, Nhung Nguyen, Ahmet Uluşan, Furkan U. Ertem, Mutian Zhang, Jia Li, Dalin Sun, Yun Huang, Shan Wang, Hon-Chiu Leung, David A. Lieberman, Laura M. Beaver, Emily Ho, Mark T. Bedford, Kyle Chang, Eduardo Vilar, Roderick H. Dashwood
openalex(2023)
加载更多
作者统计
#Papers: 75
#Citation: 1611
H-Index: 23
G-Index: 39
Sociability: 5
Diversity: 2
Activity: 24
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn